19th Nov 2015 07:00
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
19 November 2015
Constellation Healthcare Technologies, Inc.
("Constellation" or "the Company")
Trading update
Constellation Healthcare Technologies, the US-based healthcare services and technology Company, is pleased to announce that, based on year to date trading, the Board now expects the full year EBITDA of Constellation to be towards the top end of market expectations.
Paul Parmar, Chief Executive Officer of Constellation commented, "EBITDA performance for the first ten months is progressing strongly year on year, driven by greater than expected organic growth, the continued optimization of CHT's operations and being ahead of schedule with the integration of its acquisitions. Since its inception, CHT has successfully integrated 11 healthcare services businesses, and the Company now has 6000+ physicians on its platform in the US."
Enquiries:
Constellation Healthcare Technologies Paul Parmar, Chief Executive Officer
| c/o Redleaf Communications +44 (0)20 7382 4730 |
finnCap - Nominated Adviser and Joint Broker Julian Blunt / Scott Mathieson
| +44 (0)20 7220 0500 |
Stifel - Joint Broker Jonathan Senior / Giles Balleny / Ben Maddison | +44 (0)20 7710 7600 |
Redleaf Communications - PR adviser Charlie Geller / Harriet Lynch
|
+44 (0)20 7382 4730 |
Related Shares:
CHT.L